Thomson Medical Group Limited (FRA:3H5)

Thomson Medical Group Statistics

Total Valuation

FRA:3H5 has a market cap or net worth of EUR 1.06 billion. The enterprise value is 1.79 billion.

Market Cap	1.06B
Enterprise Value	1.79B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	26.44B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.52B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.42
PB Ratio	2.84
P/TBV Ratio	n/a
P/FCF Ratio	35.23
P/OCF Ratio	25.30
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 55.59, with an EV/FCF ratio of 59.48.

EV / Earnings	-60.33
EV / Sales	5.71
EV / EBITDA	55.59
EV / EBIT	192.56
EV / FCF	59.48

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 1.96.

Current Ratio	2.37
Quick Ratio	1.16
Debt / Equity	1.96
Debt / EBITDA	22.94
Debt / FCF	24.27
Interest Coverage	0.26

Financial Efficiency

Return on equity (ROE) is -7.53% and return on invested capital (ROIC) is 0.88%.

Return on Equity (ROE)	-7.53%
Return on Assets (ROA)	0.48%
Return on Invested Capital (ROIC)	0.88%
Return on Capital Employed (ROCE)	0.84%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	145,896
Profits Per Employee	-13,958
Employee Count	2,131
Asset Turnover	0.26
Inventory Turnover	1.92

Taxes

In the past 12 months, FRA:3H5 has paid 3.97 million in taxes.

Income Tax	3.97M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.59%
50-Day Moving Average	0.04
200-Day Moving Average	0.03
Relative Strength Index (RSI)	48.18
Average Volume (20 Days)	418

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:3H5 had revenue of EUR 310.90 million and -29.75 million in losses. Loss per share was -0.00.

Revenue	310.90M
Gross Profit	146.14M
Operating Income	9.22M
Pretax Income	-24.83M
Net Income	-29.75M
EBITDA	25.95M
EBIT	9.22M
Loss Per Share	-0.00

Balance Sheet

The company has 63.04 million in cash and 732.16 million in debt, with a net cash position of -669.13 million.

Cash & Cash Equivalents	63.04M
Total Debt	732.16M
Net Cash	-669.13M
Net Cash Per Share	n/a
Equity (Book Value)	374.44M
Book Value Per Share	0.01
Working Capital	115.37M

Cash Flow

In the last 12 months, operating cash flow was 42.00 million and capital expenditures -11.84 million, giving a free cash flow of 30.17 million.

Operating Cash Flow	42.00M
Capital Expenditures	-11.84M
Free Cash Flow	30.17M
FCF Per Share	n/a

Margins

Gross margin is 47.00%, with operating and profit margins of 2.96% and -9.57%.

Gross Margin	47.00%
Operating Margin	2.96%
Pretax Margin	-7.99%
Profit Margin	-9.57%
EBITDA Margin	8.35%
EBIT Margin	2.96%
FCF Margin	9.70%

Dividends & Yields

FRA:3H5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.80%
FCF Yield	2.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:3H5 has an Altman Z-Score of 1.14 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.14
Piotroski F-Score	5